Position in INCY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$45,426,264
+$40,627,920 QoQ
Shares Held
482,642
+893.5% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JUPITER ASSET MANAGEMENT LTD holds $304,105,196 across 12 Biotechnology names. INCY ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
1,608,256 | $103,941,584 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
711,457 | $48,471,564 | |
| 3 | INCY |
Incyte Corp
This page
|
482,642 | $45,426,264 | |
| 4 | EXEL |
Exelixis, Inc.
|
967,409 | $41,492,171 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
1,781,063 | $22,833,227 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
803,419 | $11,906,668 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
491,093 | $10,931,730 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
274,419 | $6,794,614 |
All Filings in INCY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,426,264 | 482,642 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,798,344 | 48,581 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $14,125,698 | 166,557 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $51,616,531 | 757,952 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $50,242,210 | 829,764 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $10,056,108 | 145,593 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $46,370,736 | 701,524 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $61,632,595 | 1,081,843 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $68,659,482 | 1,093,478 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $46,962,330 | 812,919 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $43,465,626 | 698,243 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $33,770,108 | 467,277 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $18,596,248 | 231,527 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,313,737 | 364,852 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,526,707 | 138,564 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $8,636,607 | 108,746 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $33,604,281 | 457,824 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,780,073 | 200,350 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,586,125 | 42,626 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $29,778,790 | 366,418 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $32,398,136 | 372,478 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $38,074,617 | 424,277 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||